Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (151-160 of 460) with videos related to

Pageof 46
Sort By:
Human Gene Therapy|September 25, 2012
Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylationNaoki Kunii, Yangbing Zhao, Shuguang Jiang, et al.
Nature Biotechnology|February 1, 2002
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBMarcela V Maus, Anna K Thomas, Debra G B Leonard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferationEdward Y Woo, Heidi Yeh, Christina S Chu, et al.
The Journal of Clinical Investigation|February 19, 2020
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durabilitySonia Guedan, Aviv Madar, Victoria Casado-Medrano, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2014
Engineered T cells for cancer therapyCarl H June, Marcela V Maus, Gabriela Plesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2002
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptorsJames L Riley, Mao Mao, Sumire Kobayashi, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Human Gene Therapy|August 16, 2011
Treatment of advanced leukemia in mice with mRNA engineered T cellsDavid M Barrett, Yangbing Zhao, Xiaojun Liu, et al.
Cancer Immunology Research|March 29, 2018
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell EngagerAnna Wing, Carlos Alberto Fajardo, Avery D Posey, et al.
Breast Cancer Research and Treatment|September 7, 2014
Mesothelin expression is associated with poor outcomes in breast cancerYun R Li, Rena R Xian, Amy Ziober, et al.
Pageof 46

Showing results (151-160 of 460) with videos related to

Sort By:
Pageof 46
Human Gene Therapy|September 25, 2012
Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylationNaoki Kunii, Yangbing Zhao, Shuguang Jiang, et al.
Nature Biotechnology|February 1, 2002
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBMarcela V Maus, Anna K Thomas, Debra G B Leonard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferationEdward Y Woo, Heidi Yeh, Christina S Chu, et al.
The Journal of Clinical Investigation|February 19, 2020
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durabilitySonia Guedan, Aviv Madar, Victoria Casado-Medrano, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2014
Engineered T cells for cancer therapyCarl H June, Marcela V Maus, Gabriela Plesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2002
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptorsJames L Riley, Mao Mao, Sumire Kobayashi, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Human Gene Therapy|August 16, 2011
Treatment of advanced leukemia in mice with mRNA engineered T cellsDavid M Barrett, Yangbing Zhao, Xiaojun Liu, et al.
Cancer Immunology Research|March 29, 2018
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell EngagerAnna Wing, Carlos Alberto Fajardo, Avery D Posey, et al.
Breast Cancer Research and Treatment|September 7, 2014
Mesothelin expression is associated with poor outcomes in breast cancerYun R Li, Rena R Xian, Amy Ziober, et al.
Pageof 46